AGYS vs ZBH · P/E 137, rev $319.3M vs P/E 23, rev $4.26B
Agilysys Inc (AGYS) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Agilysys Inc (AGYS) is a software - application company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported AGYS revenue for 2026-03-31 was $319.3M. Net income was $38.8M. Revenue was up 15.9% from 2025-03-31 to 2026-03-31. AGYS currently screens at market cap $3.14B and trailing P/E 136.7.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
AGYS currently screens at market cap $3.14B and trailing P/E 136.7. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the AGYS and ZBH stock pages for the full models.
Not investment advice.